We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Progress and treatment of "long COVID" in non‐hospitalized patients: A single‐center retrospective cohort study.
- Authors
Ono, Rie; Arita, Ryutaro; Takayama, Shin; Kanno, Takeshi; Kikuchi, Akiko; Suzuki, Satoko; Ohsawa, Minoru; Saito, Natsumi; Abe, Michiaki; Onodera, Koh; Akaishi, Tetsuya; Tadano, Yasunori; Ishii, Tadashi
- Abstract
Background: "Long COVID" or "post‐COVID conditions" describes prolonged symptoms after the acute phase of coronavirus disease 2019 (COVID‐19). However, there is a paucity of published reports on its treatment. Method: This retrospective cohort study included adult, non‐hospitalized patients with COVID‐19 symptoms at least one month after the onset who had been examined at the isolation facility in Miyagi prefecture between October 2020 and September 2021. Results: In total, 70 patients with a median age of 46 (21–69) years were included, and 37 were women (52.9%). The median time from onset to the end of treatment was 46 (28–396) days. Thirty‐eight patients (53.5%) showed improvement in all symptoms, while four (5.7%) did not recover within the study period. The symptoms at six months with high residual rates were dizziness (33.3%), fatigue (14.3%), myalgia (14.3%), abdominal discomfort (14.3%), and taste dysfunction (11.8%). For treatment of prolonged symptoms, formulae of Kampo medicine (Japanese traditional medicine) were used alone or in combination with Western medications in 76%, 66%, 53%, and 66% of patients at 1–2 months, 2–3 months, 3–6 months, and over 6 months respectively. Kampo formulae with anti‐inflammatory effects were used in the early period; however, tonifying formulae and blood stasis‐resolving formulae were used in the late period. Conclusion: Non‐hospitalized patients with COVID‐19 may suffer from persistent symptoms after the acute phase of infection. For the management of long COVID, a comprehensive and holistic approach is needed. Kampo medicine should be considered as a treatment option for long COVID.
- Subjects
POST-acute COVID-19 syndrome; COVID-19; JAPANESE herbal medicine; COHORT analysis; COVID-19 pandemic
- Publication
Traditional & Kampo Medicine, 2023, Vol 10, Issue 2, p150
- ISSN
2053-4515
- Publication type
Article
- DOI
10.1002/tkm2.1370